Phase I trial of HS 310 for advanced ovarian cancer.
Phase of Trial: Phase I
Latest Information Update: 02 Oct 2013
At a glance
- Drugs HS 310 (Primary)
- Indications Ovarian cancer
- Focus Therapeutic Use
- 02 Oct 2013 Planned initiation date changed from 1 Dec 2012 to 1 Dec 2013.